Capital expenditure · 2011–2025
Madrigal Pharmaceuticals capital expenditure
$467,000−68.1% · FY2025
Madrigal Pharmaceuticals (MDGL) reported $467,000 in capital expenditure for fiscal 2025, −68.1% year on year.
| Fiscal year | Capital expenditure | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $467,000 | −68.1% | Open → |
| FY20242024-12-31 | $1.5M | −1.1% | Open → |
| FY20232023-12-31 | $1.5M | +581.6% | Open → |
| FY20222022-12-31 | $217,000 | +3.8% | Open → |
| FY20212021-12-31 | $209,000 | −37.4% | Open → |
| FY20202020-12-31 | $334,000 | +94.2% | Open → |
| FY20192019-12-31 | $172,000 | +681.8% | Open → |
| FY20182018-12-31 | $22,000 | −82.4% | Open → |
| FY20172017-12-31 | $125,000 | +4,066.7% | Open → |
| FY20162016-12-31 | $3,000 | −94.8% | Open → |
| FY20152015-12-31 | $58,000 | −59.7% | Open → |
| FY20142014-12-31 | $144,000 | −81.3% | Open → |
| FY20132013-12-31 | $769,000 | +52.3% | Open → |
| FY20122012-12-31 | $505,000 | −26.8% | Open → |
| FY20112011-12-31 | $690,000 | — | Open → |
Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth −2.7%
Capital expenditure at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Madrigal Pharmaceuticals capital expenditure |url=https://companiesranked.com/en/company/madrigal-pharmaceuticals/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Madrigal Pharmaceuticals capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/madrigal-pharmaceuticals/capital-expenditureBibTeX
@misc{companiesranked-en-company-madrigal-pharmaceuticals-capital-expenditure-2026,
author = {{CompaniesRanked}},
title = {{Madrigal Pharmaceuticals capital expenditure}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/madrigal-pharmaceuticals/capital-expenditure}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001628280-26-009514 · February 19, 2026
{{cite web |title=Madrigal Pharmaceuticals capital expenditure — 10-K (0001628280-26-009514) |url=https://www.sec.gov/Archives/edgar/data/1157601/000162828026009514/mdgl-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-19}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.